✦ LIBER ✦

Avecia licenses drug technology

Publisher: Elsevier Science
Year: 2004
Weight: 44 KB
Volume: 2004
Category: Article
ISSN: 1351-4180
DOI: 10.1016/s1351-4180(04)00402-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Avecia, Rohm and Haas roll out catalyst

Avecia, Rohm and Haas roll out catalyst technology for drug makers

📂 Article 📅 2004 🏛 Elsevier Science ⚖ 34 KB

Avecia and Rohm and Haas have unveiled new polymer-enhanced catalyst technologies for drug production. Avecia has introduced an encapsulated palladium catalyst, Pd EnCat. The technology is said to promote higher throughput and cleaner reactions. In Pd EnCat, palladium and any required activating lig

Nard, Avecia ink technology deal

📂 Article 📅 2004 🏛 Elsevier Science ⚖ 34 KB

Avecia spins out pharmaceutical technolo

Avecia spins out pharmaceutical technology

📂 Article 📅 2005 🏛 Elsevier Science ⚖ 35 KB

Technology licensing

✍ Jeremy R.C. Brown 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Technology Licensing

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB

DPoint licenses Ballard humidification t

DPoint licenses Ballard humidification technology

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Because traditional fuels are expensive in Japan, and because DFCs can generate high-efficiency electricity on renewables like ADG, they hold an important competitive advantage in the Japanese market. There are approximately 200 sites in Japan that produce sufficient ADG to generate 250 kWe or more